Aspartame and Neurological Health
Recently, aspartame has garnered much debate. Used in thousands of diet sodas and sugar-free gum products and low-calorie desserts, its safety has been verified by both the Food and Drug Administration and European Food Safety Agency; yet a report by World Health Organization (WHO) called for further study because ersatz sugar may potentially cause cancer.
Researchers conducted experiments on mice to discover that high-dose aspartame intake caused significant learning and memory deficits, not only with new learning but also remembering familiar mazes or recalling what they had already learned – passing this onto their offspring through epigenetic inheritance.
Results indicate that aspartame can influence brain chemistry in various ways, including altering monoamine neurotransmitter synthesis. Phenylalanine may play an indirect role, competing for binding at large neutral amino acid transporter and inhibiting serotonin and catecholamine production – leading to decreased levels of these chemicals which in turn leads to neurological symptoms like seizures.
Though the results were troubling, the committee that performed the review of aspartame did not find enough evidence to alter its guidelines for human consumption. Indeed, for decades the World Health Organization’s panel of experts have studied aspartame and currently recommend no more than 40 milligrams per kilogram of body weight per day; for someone weighing an average American of 184 pounds this would mean they could consume 33 cans of diet soda without exceeding their daily allowance.